A small prospective, double-blind study was carried out to determine whether amphetaminefacilitated motor recovery occurs in humans aer stroke /41/. The study was carefully designed to simulate the paradigm used in the laboratory experimental studies. A group of eight patients with stable motor deficits within 10 days of ischemic stroke were randomized to receive either a single dose of amphetamine or placebo. Motor function was measured with a reliable and validated scale, the Fugl-Meyer Assessment/71/. Within three hours of drug administration, all of the patients underwent intensive physical therapy (i.e., drug administration was coupled with task-specific experience). The following day, the patients' abilities to use their affected limbs were reassessed. Overall, the amphetamine-treated group had a significant improvement in motor performance while there was little change in the placebo-treated group (Fig. 2) . However, because this study involved only a small group of highly selected patients, the results may not be applicable to stroke patients with other types of deficits. Because only short-term motor recovery was measured, the longer-term efficacy of amphetamine treatment is unknown. Until (Fig. 4) . Thus 
